This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Crimean Congo Hemorrhagic Fever Virus (CCHFV) Major Glycoprotein C Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for crimean congo hemorrhagic fever virus major glycoprotein C. It is affinity purified by protein A. It can be applied to ELISA of crimean congo hemorrhagic fever virus major glycoprotein C.
Specifications
Target Information
Crimean-congo hemorrhagic fever virus (CCHFV) is a tick-borne pathogen that causes severe hemorrhagic fever in humans and animals. The major glycoprotein C (GPC) of CCHFV is a type I transmembrane glycoprotein that plays a central role in the virus's infectivity and pathogenesis. The GPC is involved in the attachment of the virus to host cells and facilitates viral entry by mediating membrane fusion. As the most abundant glycoprotein on the surface of CCHFV virions, it is a primary target for the host immune response and is considered a key antigen for the development of diagnostic assays and vaccines.
Shipping and Storage
This product is shipped with ice gel packs. Store at -20°C (up to 12 months) on receipt. Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Haferkamp, Sebastian, et al. "Intracellular localization of Crimean-Congo hemorrhagic fever (CCHF) virus glycoproteins." Virology Journal 2 (2005): 1-14.